A former vice president and associate general counsel for the British pharmaceutical company GlaxoSmithKline was just indicted by the U.S. Justice Department on charges of making false statements and obstructing a federal investigation into illegal drug marketing. [Read the full article here.]
Lauren C. Stevens of Durham, N.C. is accused of lying to the Food and Drug Administration by denying that Glaxo had promoted the antidepressant Wellbutrin for off-label use as a weight loss treatment.
Doctors are free to use any approved drug for any use they see fit, but pharmaceutical companies are prohibited from marketing the drugs for uses that have not been approved by the F.D.A.
In October GlaxoSmithKline had agreed to pay $750 million to settle civil and criminal complaints that it sold defective drugs, including the antidepressant Paxil,Â manufacturedÂ in Puerto Rico.
While psychiatrists cry about “reducing stigma,” it is their labels and treatment that initially create the stigma. And now, they are pushing depression drugsÂ for people who want to lose weight.
[Editorial Comment: Talk about creating stigma — “you must be depressed if you want to lose weight;” give me a break!]
People are labeled “mentally ill” with diagnoses that are completely subjective and then subjected to dangerous and addictive mind-altering drugs in order to change their behavior. It’s pretty clear where the “stigmatization” is coming from. It’s coming from the mental health monopoly that stands to profit at the sake of people seeking help.
Click here for more information about the harmful effects of Wellbutrin (buproprion HCL) and Paxil (paroxetine).
Click here for more information about psychiatric fraud.
Click here for more information about the alternatives to psychiatric drugging.